Duke Industry Statistics Symposium (DISS2024)

Start Date
April 3, 2024
8:30 am
End Date
April 5, 2024
3:00 pm

Event sponsored by:

Biostatistics and Bioinformatics

Contact:

Adkins, Judy

Share

Duke Industry Statistics Symposium Logo

DISS2024 will be held in person April 3-5, 2024 with the theme "Statistical Innovation for Next-Generation Pharmaceutical Development". The symposium will explore the forefront of statistical innovation in next-generation clinical research for pharmaceutical products. For information about the program schedule, including short courses, speakers, talk abstracts, poster submission, and registration, please visit https://sites.duke.edu/diss/.

Two keynote presentations will feature the work of Dr. Peter Stein, the Director of FDA CDER's Office of New Drugs, on "Changes in the Drug Development and Regulatory Landscape: Evolutions and Revolutions" on April 4 and Dr. Venkat Sethuraman, the Sr Vice President of Global Biometrics and Data Sciences of Bristol Myers Squibb, on "The Power of AI, Data Sciences, and Technology in Drug Development" on April 5. Short courses will be offered on April 3, including AI/ML for Clinical Trials and Humanized AI for Future Healthcare, Dose Optimization, Pragmatic Benefit/Risk Evaluation, Adaptive Platform Trials, and Evaluation of Surrogate Endpoints in Oncology.

Parallel sessions with invited speakers from industry, regulatory agencies, and academics will be offered on April 4 & 5 with topics on Use of RWD to Generate RWE, Joint Modeling of Longitudinal Endpoints, Estimands for Clinical Trial, Bayesian Methods to Borrow Information in Rare Disease Trials, Optimizing Dosing in Drug Development, Covariate Adjustment in Randomized Clinical Trials, Multiple and Hieratical Outcomes in Clinical Trials, Causal Inference Methods to Estimate Treatment Effects in Clinical Trials, Statistical Innovation in ctDNA Applications in Oncology Drug Development, Bridging Early Insights for Enhanced Oncology Decision-Making, Statistical and Regulatory Consideration for Rare Disease Drugs' Approval, and Statistical Innovation in Biosimilar and Bioequivalence Studies.

The symposium will offer discounted registration fees for students and postdoctoral scholars with majors in statistics, biostatistics, and data sciences and Duke faculty. We invite submissions for poster presentations, the poster lightning talk session, and the poster award competition. The poster session and the poster lightning talk session offer a great opportunity for graduate students or junior researchers to share their research work.

For more details regarding the poster sessions and how to request a promo code for discounted registration, please visit our website.